Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherCurrent Practice

Answer: Can you identify this condition?

Vimal Prajapati and Benjamin Barankin
Canadian Family Physician May 2008; 54 (5) 699;
Vimal Prajapati
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Barankin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Answer to Dermacase continued from page 691

2. Actinic keratosis

Actinic keratosis (AK), or solar keratosis, is one of the most common presentations in dermatology clinics. A precancerous lesion, AK has the potential to develop into invasive squamous cell carcinoma (SCC). The average rate of progression ranges from 0.025% to 16% per year; however, the exact rate is controversial.1 The most important risk factors for developing AK are fair skin and cumulative sun exposure.2 As such, it is seen almost exclusively in white people with Fitzpatrick skin phototypes I and II; prevalence increases with age, outdoor occupation, and geographic location closer to the equator.3 Other risk factors include immunosuppression (eg, organ transplant patients) and genetic skin disorders, such as xeroderma pigmentosum.2 Men are more frequently affected.

Typically, AK presents as rough, scaly, poorly demarcated erythematous papules or plaques on sun-exposed areas of the skin. Lesions can be skin-coloured or yellow-brown, although this is less common. A pigmented brown-black variant also exists. Scales are adherent, difficult to remove, and often felt before they can be seen. Over time, lesions can thicken or become hypertrophic.4 Usually asymptomatic, AK might present (uncommonly) with tenderness, burning, or pruritus.2

Actinic keratosis occurs as multiple scattered or con-fluent lesions on the head, neck, and dorsa of the hands and forearms. On the face, the nose, cheeks, temples, and forehead are most frequently affected. In male patients, lesions might occur on the ears and scalp as well, particularly in the presence of androgenic alopecia. Actinic keratosis tends to arise on a background of dry, sun-damaged skin with wrinkles, yellowish discolouration, blotchy pigmentation, and telangiectasia.2

Diagnosis

Most often diagnosed clinically, the differential diagnosis includes seborrheic keratosis, Bowen disease (SCC in situ), SCC, superficial basal cell carcinoma, and lentigo maligna.2,5 Seborrheic keratosis can be differentiated from AK by its well-defined margins and greasy “stuck on” appearance. Bowen disease and superficial basal cell carcinoma typically present with larger well-defined plaques. However, SCC is clinically indistinguishable from hypertrophic AK. Likewise, lentigo maligna cannot be differentiated with certainty from pigmented AK. Biopsy should be considered for thickened or pigmented papules.

Treatment

Actinic keratosis can regress, remain unchanged, or progress to SCC.6 Up to 25% of AK spontaneously disappears within a year.7 However, new lesions develop and patients still experience spreading of AK with age.

The rationale for treating AK is to prevent progression to SCC. As it is not possible to determine which papules will progress to SCC, treatment of all AK-related lesions is recommended.8 Several highly effective treatments are available. Cryotherapy with liquid nitrogen is most common. Liquid nitrogen can be sprayed or applied with a cotton-tipped applicator. More intense, lengthy application might be required for hypertrophic lesions. Most AK will clear with cryotherapy, although several treatment sessions might be required. Disadvantages include pain and discomfort during treatment, dyspigmentation, redness, and blistering after treatment, which can take 2 to 3 weeks to heal.9 Cryotherapy is the treatment of choice for patients with few lesions although it can be used to treat widespread AK as well. Curettage with or without electrodesiccation is also useful and effective for treating a small number of lesions.

Topical chemotherapeutic agents, such as 5-fluorouracil cream (5-FU), imiquimod, and, less common, tretinoin and diclofenac gel, are also used to treat AK but are generally reserved for patients with widespread lesions. Five percent 5-FU cream is applied twice daily to affected areas for 2 to 4 weeks. Within a few days, the lesions become erythematous, crusted, and eventually erode. Patients experience pain, burning, and pruritus.9 Although effective, 5-FU causes substantial irritation and temporary cosmetic disfigurement. Patients should be warned about these side effects. Typically, 5% imiquimod cream is applied once daily, 3 times a week, for 16 weeks; however, other regimens have been developed to reduce discomfort and increase compliance. Side effects are similar to 5-FU but might be better tolerated.

Other treatments include topical 5-aminolevulinic acid photodynamic therapy, dermabrasion, chemical peels, laser surgery, and oral retinoids. Despite the many effective treatments available, the best treatment is prevention. Sun-protection measures, such as protective clothing and sunscreen, are recommended.8

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    GlogauRGThe risk of progression to invasive diseaseJ Am Acad Dermatol2000421 Pt 2234
    OpenUrlCrossRefPubMed
  2. ↵
    MoyRLClinical presentation of actinic keratoses and squamous cell carcinomaJ Am Acad Dermatol2000421 Pt 2810
    OpenUrlCrossRefPubMed
  3. ↵
    SalascheSJEpidemiology of actinic keratoses and squamous cell carcinomaJ Am Acad Dermatol2000421 Pt 247
    OpenUrlCrossRefPubMed
  4. ↵
    BillanoRALittleWPHypertrophic actinic keratosisJ Am Acad Dermatol1982744849
    OpenUrlPubMed
  5. ↵
    FrostCAGreenACEpidemiology of solar keratosesBr J Dermatol1994131445564
    OpenUrlPubMed
  6. ↵
    CallenJPBickersDRMoyRLActinic keratosesJ Am Acad Dermatol19973646503
    OpenUrlCrossRefPubMed
  7. ↵
    MarksRFoleyPGoodmanGHageBHSwelwoodTSSpontaneous remission of solar keratoses: the case for conservative managementBr J Dermatol1986115664955
    OpenUrlCrossRefPubMed
  8. ↵
    DinehartSMThe treatment of actinic keratosesJ Am Acad Dermatol2000421 Pt 2258
    OpenUrlCrossRefPubMed
  9. ↵
    SilapuntSGoldbergLHAlamMTopical and light-based treatments for actinic keratosesSemin Cutan Med Surg200322316270
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (5)
Canadian Family Physician
Vol. 54, Issue 5
1 May 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Answer: Can you identify this condition?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Answer: Can you identify this condition?
Vimal Prajapati, Benjamin Barankin
Canadian Family Physician May 2008, 54 (5) 699;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Answer: Can you identify this condition?
Vimal Prajapati, Benjamin Barankin
Canadian Family Physician May 2008, 54 (5) 699;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • 2. Actinic keratosis
    • Diagnosis
    • Treatment
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • Question: Can you identify this condition?
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Current Practice

  • Intraprofessional relationships
  • Scurvy
  • Lyme disease
Show more Current Practice

Dermacase

  • Question: Can you identify this condition?
  • Answer: Can you identify this condition?
  • Question: Can you identify this condition?
Show more Dermacase

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire